Not applicableStudy completedNCT01833325What this trial is testingProton Radiation Therapy for Macular DegenerationWho this might be right forAge-Related Macular Degeneration University of Florida 9
Not applicableStudy completedNCT01712035What this trial is testingNeovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Oregon Health and Science University 44
Large-scale testing (Phase 3)Looking for participantsNCT07440225What this trial is testingA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)Who this might be right forMacular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more EyeBiotech Ltd. 960
Testing effectiveness (Phase 2)Study completedNCT00376701What this trial is testingCombination Therapy for Age-Related Macular Degeneration.Who this might be right forAge Related Macular Degeneration London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Not applicableStudy completedNCT05969418What this trial is testingDeep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVCWho this might be right forMacular Degeneration Choroidal Neovascularization Federico II University 50
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Not applicableEnded earlyNCT02625376What this trial is testingResveratrol for Exudative Age-Related Macular DegenerationWho this might be right forAMDAge-related Macular DegenerationChoroidal Neovascularisation Poitiers University Hospital 25
Testing effectiveness (Phase 2)Study completedNCT00733304What this trial is testingAn Extension to Study MD7108240Who this might be right forMacular Degeneration GlaxoSmithKline 42
Testing effectiveness (Phase 2)Study completedNCT01157715What this trial is testingA Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMDWho this might be right forNeovascular Age-related Macular Degeneration Chengdu Kanghong Biotech Co., Ltd. 122
Large-scale testing (Phase 3)Study completedNCT04264819What this trial is testingStudy of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Looking for participantsNCT05407636What this trial is testingPivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDWho this might be right forAMDnAMDWet Age-related Macular Degeneration+3 more AbbVie 714
Post-approval studies (Phase 4)Study completedNCT01453920What this trial is testingWet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab DosingWho this might be right forAge Related Macular Degeneration University Health Network, Toronto 44
Testing effectiveness (Phase 2)Study completedNCT03038880What this trial is testingStudy to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular DegenerationWho this might be right forNeovascularization, ChoroidalMacular Degeneration, Age-Related Hoffmann-La Roche 76
Large-scale testing (Phase 3)Ended earlyNCT01940900What this trial is testingSafety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® MonotherapyWho this might be right forAge-Related Macular Degeneration Ophthotech Corporation 627
Early research (Phase 1)Ended earlyNCT01334255What this trial is testingISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPigment Epithelial Detachment Lpath, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT01025232What this trial is testingIntravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)Who this might be right forAge Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more David M. Brown, M.D. 88
Large-scale testing (Phase 3)Study completedNCT00090623What this trial is testingRhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Genentech, Inc. 180
Not applicableUnknownNCT02988895What this trial is testingEpiscleral Brachytherapy for the Treatment of Wet AMDWho this might be right forMacular Degeneration, Choroidal Neovascularization Salutaris Medical Devices, Inc. 11
Post-approval studies (Phase 4)Ended earlyNCT05473715What this trial is testingLearn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of TreatmentWho this might be right forNeovascular (Wet) Age-related Macular Degeneration Bayer 3
Testing effectiveness (Phase 2)Study completedNCT00043680What this trial is testingCelecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic TherapyWho this might be right forMacular Degeneration National Eye Institute (NEI) 60